Goodman GR - Search Results

1

Goodman GR, Bethel KJ, Saven A. Goodman GR, et al. Curr Opin Hematol. 2003 Jul;10(4):258-66. doi: 10.1097/00062752-200307000-00002. Curr Opin Hematol. 2003. PMID: 12799530 Review.

2

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.

Goodman GR, Burian C, Koziol JA, Saven A. Goodman GR, et al. J Clin Oncol. 2003 Mar 1;21(5):891-6. doi: 10.1200/JCO.2003.05.093. J Clin Oncol. 2003. PMID: 12610190

3

Cladribine in the treatment of hairy-cell leukaemia.

Goodman GR, Beutler E, Saven A. Goodman GR, et al. Best Pract Res Clin Haematol. 2003 Mar;16(1):101-16. doi: 10.1016/s1521-6926(02)00089-0. Best Pract Res Clin Haematol. 2003. PMID: 12670469 Review.

4

A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2.

Meyers FJ, Paradise C, Scudder SA, Goodman G, Konrad M. Meyers FJ, et al. Clin Pharmacol Ther. 1991 Mar;49(3):307-13. doi: 10.1038/clpt.1991.33. Clin Pharmacol Ther. 1991. PMID: 2007324 Clinical Trial.

5

Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinoma.

Bukowski RM, Young J, Goodman G, Meyers F, Issell BF, Sergi JS, McLain D, Fyfe G, Finke J. Bukowski RM, et al. Invest New Drugs. 1993 May-Aug;11(2-3):211-7. doi: 10.1007/BF00874158. Invest New Drugs. 1993. PMID: 8262734 Clinical Trial.

6

High-dose cisplatin in disseminated melanoma: a comparison of two schedules.

Mortimer JE, Schulman S, MacDonald JS, Kopecky K, Goodman G. Mortimer JE, et al. Cancer Chemother Pharmacol. 1990;25(5):373-6. doi: 10.1007/BF00686241. Cancer Chemother Pharmacol. 1990. PMID: 2306798

7

High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.

Holmberg LA, Demirer T, Rowley S, Buckner CD, Goodman G, Maziarz R, Klarnet J, Zuckerman N, Harrer G, McCloskey R, Gersh R, Goldberg R, Nichols W, Jacobs A, Weiden P, Montgomery P, Rivkin S, Appelbaum FR, Bensinger WI. Holmberg LA, et al. Bone Marrow Transplant. 1998 Oct;22(7):651-9. doi: 10.1038/sj.bmt.1701398. Bone Marrow Transplant. 1998. PMID: 9818692

8

Interferon-gamma induced by administration of recombinant interleukin-2 to patients with cancer: kinetics, dose dependence, and correlation with physiological and therapeutic response.

Konrad MW, DeWitt SK, Bradley EC, Goodman G, Groves EC, Hersh EM, Krigel RL, Rudolph A. Konrad MW, et al. J Immunother (1991). 1992 Jul;12(1):55-63. doi: 10.1097/00002371-199207000-00007. J Immunother (1991). 1992. PMID: 1637783 Clinical Trial.

9

Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb.

Pitsch RJ, Goodman GR, Minion DJ, Madura JA 2nd, Fox PL, Graham LM. Pitsch RJ, et al. Among authors: goodman gr. J Vasc Surg. 1996 May;23(5):783-91. doi: 10.1016/s0741-5214(96)70240-9. J Vasc Surg. 1996. PMID: 8667499 Free article.

10

The proliferative response to platelet-derived growth factor of smooth muscle cells isolated from synthetic vascular grafts in a canine model.

Minion DJ, van de Kerkhove MP, Goodman GR, van Aalst JA, Absood A, Fox PL, Graham LM. Minion DJ, et al. Among authors: goodman gr. J Vasc Surg. 1999 May;29(5):845-50; discussion 851. doi: 10.1016/s0741-5214(99)70212-0. J Vasc Surg. 1999. PMID: 10231636 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page